Style | Citing Format |
---|---|
MLA | Ghazanfari M, et al.. "Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis?." Current Medical Mycology, vol. 6, no. 2, 2020, pp. 7-10. |
APA | Ghazanfari M, Fattahi A, Falahati M, Bakhshizadeh M, Roudbary M, Jazi FM, Keykhosravi M, Lotfali E (2020). Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis?. Current Medical Mycology, 6(2), 7-10. |
Chicago | Ghazanfari M, Fattahi A, Falahati M, Bakhshizadeh M, Roudbary M, Jazi FM, Keykhosravi M, Lotfali E. "Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis?." Current Medical Mycology 6, no. 2 (2020): 7-10. |
Harvard | Ghazanfari M et al. (2020) 'Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis?', Current Medical Mycology, 6(2), pp. 7-10. |
Vancouver | Ghazanfari M, Fattahi A, Falahati M, Bakhshizadeh M, Roudbary M, Jazi FM, et al.. Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis?. Current Medical Mycology. 2020;6(2):7-10. |
BibTex | @article{ author = {Ghazanfari M and Fattahi A and Falahati M and Bakhshizadeh M and Roudbary M and Jazi FM and Keykhosravi M and Lotfali E}, title = {Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis?}, journal = {Current Medical Mycology}, volume = {6}, number = {2}, pages = {7-10}, year = {2020} } |
RIS | TY - JOUR AU - Ghazanfari M AU - Fattahi A AU - Falahati M AU - Bakhshizadeh M AU - Roudbary M AU - Jazi FM AU - Keykhosravi M AU - Lotfali E TI - Does Alternation of Candida Albicans Tup1 Gene Expression Affect the Progress of Symptomatic Recurrent Vulvovaginal Candidiasis? JO - Current Medical Mycology VL - 6 IS - 2 SP - 7 EP - 10 PY - 2020 ER - |